This is a preview of subscription content, log in via an institution to check access.
Notes
2018 euros
Reference
Jang M, et al. Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets. BioDrugs : 24 Dec 2020. Available from: URL: http://doi.org/10.1007/s40259-020-00461-8
Rights and permissions
About this article
Cite this article
Use of intravenous biosimilars cost saving in EU countries. PharmacoEcon Outcomes News 870, 32 (2021). https://doi.org/10.1007/s40274-021-7435-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7435-3